Skip to main content

February 2020 Vol 13, Special Issue: Payers' Perspectives in Oncology

Lymphoma
Nivolumab Monotherapy as Bridge to Transplant in Patients with Relapsed or Refractory Hodgkin Lymphoma
Wayne Kuznar
Read More
Practice Management
Real-World Healthcare Utilization and Costs Support Broader Use of CAR T-Cell Therapy
Phoebe Starr
Read More
Multiple Myeloma, Oncology
Dual-Targeted CAR T-Cell Therapy Leads to Very High Response Rates in Relapsed or Refractory Multiple Myeloma
Phoebe Starr
Read More
Cholangiocarcinoma, Oncology
Surgery for Cholangiocarcinoma
Read More
In the Literature, Oncology
Real-World Evidence Supports Patient Navigation in Cancer
Read More
Investigational BET Inhibitor, CPI-0610, Promotes Responses in Myelofibrosis
Wayne Kuznar
Read More
Page 3 of 3
Results 21 - 26 of 26